Ionis Pharmaceuticals Inc (IONS)
41.99
+0.40
(+0.96%)
USD |
NASDAQ |
Apr 29, 16:00
41.98
-0.01
(-0.02%)
After-Hours: 20:00
Ionis Pharmaceuticals Price to Book Value: 15.84 for April 29, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 15.84 |
| April 26, 2024 | 15.69 |
| April 25, 2024 | 15.78 |
| April 24, 2024 | 16.01 |
| April 23, 2024 | 15.78 |
| April 22, 2024 | 15.49 |
| April 19, 2024 | 15.34 |
| April 18, 2024 | 15.39 |
| April 17, 2024 | 15.43 |
| April 16, 2024 | 15.67 |
| April 15, 2024 | 15.67 |
| April 12, 2024 | 15.74 |
| April 11, 2024 | 16.03 |
| April 10, 2024 | 16.20 |
| April 09, 2024 | 16.15 |
| April 08, 2024 | 15.93 |
| April 05, 2024 | 16.30 |
| April 04, 2024 | 16.15 |
| April 03, 2024 | 16.51 |
| April 02, 2024 | 16.22 |
| April 01, 2024 | 16.57 |
| March 28, 2024 | 16.34 |
| March 27, 2024 | 16.83 |
| March 26, 2024 | 16.63 |
| March 25, 2024 | 16.55 |
| Date | Value |
|---|---|
| March 22, 2024 | 16.10 |
| March 21, 2024 | 16.11 |
| March 20, 2024 | 16.12 |
| March 19, 2024 | 15.89 |
| March 18, 2024 | 15.84 |
| March 15, 2024 | 16.04 |
| March 14, 2024 | 15.90 |
| March 13, 2024 | 16.27 |
| March 12, 2024 | 16.27 |
| March 11, 2024 | 16.31 |
| March 08, 2024 | 16.58 |
| March 07, 2024 | 16.84 |
| March 06, 2024 | 16.69 |
| March 05, 2024 | 16.66 |
| March 04, 2024 | 16.91 |
| March 01, 2024 | 17.14 |
| February 29, 2024 | 17.04 |
| February 28, 2024 | 17.54 |
| February 27, 2024 | 17.87 |
| February 26, 2024 | 17.38 |
| February 23, 2024 | 17.10 |
| February 22, 2024 | 16.58 |
| February 21, 2024 | 16.41 |
| February 20, 2024 | 16.72 |
| February 16, 2024 | 16.75 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
3.937
Minimum
Mar 23 2020
23.48
Maximum
Dec 01 2023
9.436
Average
8.452
Median
May 06 2019
Price to Book Value Benchmarks
| Madrigal Pharmaceuticals Inc | 9.870 |
| Viking Therapeutics Inc | 8.905 |
| Alnylam Pharmaceuticals Inc | -- |
| Akero Therapeutics Inc | 2.527 |
| 89bio Inc | 1.515 |
Price to Book Value Related Metrics
| PS Ratio | 7.634 |
| PEG Ratio | -0.4722 |
| Price | 41.99 |
| Earnings Yield | -6.10% |
| Market Cap | 6.124B |
| PEGY Ratio | -0.4722 |